Yakult Honsha Co., Ltd. (Japan) and Nestle (Switzerland) are Leading Players in the Asia Pacific Human Microbiome Market
The Asia Pacific human microbiome market is expected to grow from USD 0.26 billion in 2025 to USD 1.31 billion by 2031, at a strong CAGR of 31.0%. Key players in the market include Yakult Honsha Co., Ltd. (Japan), International Flavors & Fragrances Inc. (US), Nestlé (Switzerland), Guangzhou Zhiyi Biotechnology Co., Ltd. (China), Microba (Australia), BiomeBank (Australia), Ferring B.V. (Switzerland), and Metagen Therapeutics, Inc. (Japan). These companies continue to expand through partnerships, product launches, acquisitions, and clinical advances. In February 2024, BiomeBank received a USD 2.15 million grant from the Australian Government's Cooperative Research Centres Projects to open a manufacturing facility for cultured microbial therapeutics in Adelaide.
Yakult Honsha is a worldwide leader in the field of probiotics and human microbiome. Its product range comprises probiotic beverages, functional foods, and microbiome-targeted formulations, with a primary focus on digestive health, immunity, and general health. Yakult is well-positioned globally, with a distribution network spanning the Asia Pacific region, Europe, and the Americas. This network is supported by its large-scale production facilities and a high level of consumer trust. To advance science, the company invests significantly in clinical research, strain development, and microbiome science at its Shirota Health Science Centers and through collaboration with hospitals and research institutes.
To know about the assumptions considered for the study download the pdf brochure
Through its Health & Biosciences division, International Flavors & Fragrances Inc. (IFF) provides probiotic, prebiotic, and postbiotic ingredient solutions. Its product portfolio includes the clinically studied HOWARU brand of strains used in dietary supplements, functional foods, infant formula, and personalized nutrition products. IFF provides brands with high-quality solutions in microbial strains and fermentation-derived ingredients throughout the Asia Pacific region. The company's research & development is fueled by its fermentation technology, a proprietary library of strains, and robust clinical trials. Further investment in microbiome innovation and ingredient personalization is enabling IFF to consolidate its position in the microbiome sector in the Asia Pacific region.
Nestlé is a leading company worldwide in nutrition and microbiome-related products. Its product range includes infant nutrition, medical nutrition, and consumer health products that support a healthy gut, immune system, and metabolic wellness. Nestlé's products are available throughout the Asia-Pacific region through retail, clinical, and digital channels. The company's R&D is powered by Nestlé Health Science and a number of global research centers, enabling robust clinical testing, strain innovation, and precision nutrition development. Nestlé continues to expand its microbiome expertise through partnerships, acquisitions, and investment in next-generation nutrition therapies.
Market Ranking
The Asia-Pacific human microbiome market is moderately consolidated. Yakult is at the forefront, with its well-validated Lactobacillus casei Shirota strain and widespread distribution of probiotic beverages. IFF is a market leader, with HOWARU probiotic strains used in supplements, functional foods, and infant nutrition. Nestlé contributes to this market through microbiome-focused nutrition products, including prebiotics (IFF) and HMOs. These firms are the main pillars of regional expansion, supporting market growth through continuous research and development (R&D), clinical collaborations, and advances in fermentation and formulation technologies.
Related Reports:
Asia Pacific Human Microbiome Market by Drugs & Supplements (Drugs, Probiotics, Prebiotics), Disease (Infectious, Gastrointestinal, Endocrine & Metabolic Disease), Type (BCT/FMT, LBP), End User (Hospitals, Clinics, Long-term Care) - Forecast to 2031
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
SEND ME A FREE SAMPLE
